STOCK TITAN

Petmed Express Inc Stock Price, News & Analysis

PETS Nasdaq

Welcome to our dedicated page for Petmed Express news (Ticker: PETS), a resource for investors and traders seeking the latest updates and insights on Petmed Express stock.

PetMed Express Inc (PETS), America's largest online pet pharmacy, provides this centralized hub for official corporate communications and market-moving developments. Access verified press releases, SEC filings, and strategic announcements from the nation's leading direct-to-consumer pet medication provider.

Investors and industry observers will find comprehensive coverage of financial results, regulatory updates, product innovations, and partnership agreements. Our curated news feed tracks material events impacting PETS' position in the $100B pet healthcare market, including prescription medication approvals and e-commerce platform enhancements.

Key updates include quarterly earnings disclosures, FDA compliance announcements, and distribution network expansions. All content is sourced directly from company filings and official statements to ensure regulatory compliance and factual accuracy.

Bookmark this page for real-time access to PETS' corporate communications, including 8-K filings detailing material events and 10-K annual reports. Check regularly for updates on the company's mission to deliver affordable pet healthcare through its innovative online pharmacy model.

Rhea-AI Summary

PetMed Express, Inc. (NASDAQ: PETS) reported a 7.9% decline in net sales for Q4 FY2022, totaling $66.0 million, down from $71.7 million in the previous year. Net income also dropped 11% to $6.1 million, or $0.30 per diluted share. For the full fiscal year, sales decreased 11.6% to $273.4 million, with net income declining to $21.1 million from $30.6 million. CEO Matt Hulett noted a potential turnaround in sales for flea and tick products, influenced by weather conditions. The company declared a quarterly dividend of $0.30 per share, payable on May 27, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.78%
Tags
dividends earnings
-
Rhea-AI Summary

PetMed Express has appointed Carolyn Carden as the new VP of Product Management, effective May 9, 2022. Carden, a former Petco executive with over 20 years of experience in eCommerce and product management, will focus on expanding the company’s product portfolio, particularly in the growing telemedicine sector. CEO Matt Hulett emphasized Carden's strategic leadership capabilities as an asset to PetMeds' growth-oriented vision, especially in enhancing its service to over 2 million pet parents and collaborating with tens of thousands of veterinarians.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.1%
Tags
management
-
Rhea-AI Summary

PetMed Express, Inc. (NASDAQ: PETS) will report its financial results for the fiscal year and fourth quarter ending March 31, 2022, on May 9, 2022, at 4:00 P.M. Eastern Time. A conference call will follow at 4:30 P.M. to discuss the results. Interested parties can access the call by dialing (800) 891-8256 or through a webcast link provided in the release. The replay will be available after the event until May 23, 2022. PetMed Express specializes in delivering pet medications and health products to consumers across the USA.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
Rhea-AI Summary

Vetster, a prominent pet care marketplace, has successfully raised $30M USD in an oversubscribed Series B round, totaling $40M USD since its launch in November 2020. The investment, led by Kensington Capital Partners, includes PetMed Express, Inc. (PETS) as a strategic partner to enhance telehealth services for pet owners in the U.S. The partnership aims to streamline pet care experiences, enabling pet parents to quickly access veterinary services and prescriptions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.18%
Tags
none
-
Rhea-AI Summary

PetMed Express announces a new partnership with Vetster Inc., enhancing pet healthcare through 24/7 telehealth access for over 2 million pet parents. This groundbreaking alliance positions PetMeds as the exclusive e-commerce provider for Vetster, which will offer virtual veterinary services. As part of the agreement, PetMeds also invests in Vetster, allowing for potential future equity growth based on performance milestones. This collaboration aims to improve accessibility for pet healthcare while maintaining fast medication delivery for customers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.18%
Tags
partnership
-
Rhea-AI Summary

PetMed Express, Inc. (NASDAQ: PETS) announces the appointment of Diana Garvis Purcel as an independent director on its Board, effective April 4, 2022. Purcel will also lead the Audit Committee following the retirement of Ronald Korn in July 2022. Board Chairman, Dr. Gian Fulgoni, highlighted Purcel's expertise as beneficial for the company's growth strategies. With over 20 years of CFO experience, including leadership roles in publicly traded companies, Purcel aims to contribute significantly to PetMed's transformation and future success.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.91%
Tags
management
Rhea-AI Summary

PetMed Express announced its Q3 2021 financial results, reporting net sales of $60.7 million, a 7.9% decrease from the previous year. For the nine months, net sales were $207.4 million, down 12.7%. The net income for the quarter declined 44% to $4.3 million, equating to $0.21 diluted per share. Adjusted EBITDA also fell 31% to $7.6 million. Despite these declines, the average order size increased slightly from $88 to $89. The Board declared a quarterly dividend of $0.30 per share, payable on February 18, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.98%
Tags
dividends earnings
-
Rhea-AI Summary

PetMed Express, Inc. (NASDAQ: PETS) will announce its financial results for Q3 2021 on January 24, 2022, at 4:00 PM ET, followed by a conference call at 4:30 PM ET. The call is accessible to the public through a toll-free number and will also be available via webcast. For those who cannot attend live, a replay will be available from 7:30 PM ET on January 24 until February 7, 2022. Founded in 1996, PetMed Express provides prescription and non-prescription pet medications and health products directly to consumers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.75%
Tags
-
Rhea-AI Summary

PetMed Express, Inc. announced the hiring of three executives to drive its digital transformation and growth. Mark Moseley joins as Chief Technology and Information Officer, bringing 17 years of experience from Rosetta Stone. Dan Pingree is the new Chief Marketing Officer, known for his role in selling Moosejaw to Walmart, along with experience at Drugstore.com. Jacqueline Smith takes the role of Vice President of People, previously leading HR at Anju Software. CEO Matt Hulett emphasizes these hires are crucial for enhancing the company's e-commerce capabilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.97%
Tags
management
Rhea-AI Summary

PetMed Express (NASDAQ: PETS) reported a 10.7% decrease in net sales for Q2 2021, totaling $67.4 million compared to $75.4 million in Q2 2020. For the first half, sales dropped 14.5% to $146.7 million. Net income fell 24.5% to $6.3 million or $0.31 per share, down from $8.4 million or $0.42 per share year-over-year. The company launched the “AutoShip and Save” program to enhance customer retention. A quarterly dividend of $0.30 per share has been declared, payable on November 19, 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.57%
Tags
dividends earnings

FAQ

What is the current stock price of Petmed Express (PETS)?

The current stock price of Petmed Express (PETS) is $3.54 as of May 6, 2025.

What is the market cap of Petmed Express (PETS)?

The market cap of Petmed Express (PETS) is approximately 71.9M.
Petmed Express Inc

Nasdaq:PETS

PETS Rankings

PETS Stock Data

71.88M
14.78M
21.81%
45.3%
8.22%
Pharmaceutical Retailers
Retail-drug Stores and Proprietary Stores
Link
United States
DELRAY BEACH